Bank Of America Corp Compugen LTD Transaction History

Bank Of America Corp

$1.12 Trillion
Q2 2024

A detailed history of Bank Of America Corp transactions in Compugen LTD stock. As of the latest transaction made, Bank Of America Corp holds 14,019 shares of CGEN stock, worth $24,393. This represents 0.0% of its overall portfolio holdings.

Number of Shares

14,019

Previous 9,812 42.88%

Holding current value

$24,393

Previous $25,000 8.0%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$1.68 - $2.52 $7,067 - $10,601	4,207 Added 42.88%	14,019 $23,000
Q1 2024 May 15, 2024	BUY	$1.75 - $2.95 $339 - $572	194 Added 2.02%	9,812 $25,000
Q4 2023 Feb 14, 2024	BUY	$0.53 - $2.0 $666 - $2,516	1,258 Added 15.05%	9,618 $19,000
Q2 2023 Aug 14, 2023	SELL	$0.57 - $1.38 $48,148 - $116,569	-84,471 Reduced 90.99%	8,360 $9,000
Q1 2023 May 12, 2023	BUY	$0.68 - $1.11 $45,220 - $73,816	66,501 Added 252.57%	92,831 $64,000
Q4 2022 Feb 10, 2023	BUY	$0.58 - $1.2 $622 - $1,287	1,073 Added 4.25%	26,330 $18,000
Q3 2022 Nov 14, 2022	SELL	$0.66 - $2.32 $84,061 - $295,489	-127,366 Reduced 83.45%	25,257 $17,000
Q2 2022 Aug 12, 2022	SELL	$1.57 - $3.33 $80,894 - $171,578	-51,525 Reduced 25.24%	152,623 $282,000
Q1 2022 May 16, 2022	BUY	$2.76 - $4.64 $199,296 - $335,049	72,209 Added 54.73%	204,148 $657,000
Q4 2021 Feb 08, 2022	BUY	$4.09 - $7.16 $212,635 - $372,241	51,989 Added 65.03%	131,939 $568,000
Q3 2021 Nov 15, 2021	BUY	$5.8 - $8.02 $120,848 - $167,104	20,836 Added 35.25%	79,950 $477,000
Q2 2021 Sep 13, 2021	BUY	$6.87 - $9.16 $406,113 - $541,484	59,114 New	59,114 $490,000

Others Institutions Holding CGEN

# of Institutions

Shares Held

13.3M

Call Options Held

191K

Put Options Held

135K

View Full List

About COMPUGEN LTD

Ticker CGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,624,600
Market Cap $151M
Description
Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tu...

More about CGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Account

Bank Of America Corp Compugen LTD Transaction History